Cargando…

Aortic arch endovascular branch and fenestrated repair: Initial Canadian experience with novel technology

OBJECTIVE: The objective is to describe the initial Canadian experience using novel aortic arch branched endograft technologies. METHODS: We performed a retrospective consecutive case series of all patients undergoing aortic arch branched repair with newly available endograft technology since 2020 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rockley, Mark, Rommens, Kenton L., McClure, R. Scott, Herget, Eric J., Smith, Holly N., Moore, Randy D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562848/
https://www.ncbi.nlm.nih.gov/pubmed/37822947
http://dx.doi.org/10.1016/j.jvscit.2023.101274
_version_ 1785118220631408640
author Rockley, Mark
Rommens, Kenton L.
McClure, R. Scott
Herget, Eric J.
Smith, Holly N.
Moore, Randy D.
author_facet Rockley, Mark
Rommens, Kenton L.
McClure, R. Scott
Herget, Eric J.
Smith, Holly N.
Moore, Randy D.
author_sort Rockley, Mark
collection PubMed
description OBJECTIVE: The objective is to describe the initial Canadian experience using novel aortic arch branched endograft technologies. METHODS: We performed a retrospective consecutive case series of all patients undergoing aortic arch branched repair with newly available endograft technology since 2020 at our site. We describe the patient characteristics, treatment characteristics, and postoperative outcomes. RESULTS: Eleven patients received arch branched endografts, indicated for penetrating aortic ulcer in seven patients (64%), arch degeneration after prior aortic dissection repair in three (27%), and acute aortobronchial fistula in one patient (9%). Their average age was 72 ± 7 years. Complete arch repair from zone 0 to 4 was performed in six cases (55%); the remaining repairs landed proximally in zones 1 or 2. Seven repairs used a single retrograde facing inner branch (thoracic branch endoprosthesis; W.L. Gore & Associates), three used double antegrade inner branch (Bolton Relay; Terumo Interventional Systems), and one emergent case used double in situ fenestrations. Seven repairs (64%) used an adjunctive extra-anatomic bypass to complete great vessel perfusion, two of which were created during a prior aortic repair. Inferior vena cava balloon inflow occlusion during deployment was used in all cases. No mortalities, transient or permanent spinal cord paralysis, myocardial infarction, dialysis dependence, venous thromboembolism, or bleeding requiring reintervention occurred. No patient undergoing elective arch branch repair experienced a stroke. The one patient undergoing emergent repair did suffer a stroke. The median length of stay was 5 days (interquartile range, 2-8 days). Two endoleaks developed: a type Ia endoleak successfully treated with a Palmaz stent (Cordis) during the index admission, and a type II endoleak with ongoing sac regression on postoperative follow-up. Postoperatively, one patient suffered a suspected aortic graft infection that was treated with lifelong antibiotics. During a mean radiographic follow-up of 7.2 months, no cases of branch vessel instability (ie, no migration, reintervention, arterial rupture, intraluminal thrombus, occlusion, stenosis, or kinking of the branch grafts) developed. Three patients experienced sac regression of >5 mm, and no patient experienced continued postoperative dilation. CONCLUSIONS: To the best of our knowledge, this is the largest reported Canadian volume of aortic arch repair using novel branched or fenestrated technology. The series demonstrates that a multidisciplinary program and properly selected patients can yield excellent results using endovascular repair for complex aortic arch pathology.
format Online
Article
Text
id pubmed-10562848
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105628482023-10-11 Aortic arch endovascular branch and fenestrated repair: Initial Canadian experience with novel technology Rockley, Mark Rommens, Kenton L. McClure, R. Scott Herget, Eric J. Smith, Holly N. Moore, Randy D. J Vasc Surg Cases Innov Tech Innovative technique OBJECTIVE: The objective is to describe the initial Canadian experience using novel aortic arch branched endograft technologies. METHODS: We performed a retrospective consecutive case series of all patients undergoing aortic arch branched repair with newly available endograft technology since 2020 at our site. We describe the patient characteristics, treatment characteristics, and postoperative outcomes. RESULTS: Eleven patients received arch branched endografts, indicated for penetrating aortic ulcer in seven patients (64%), arch degeneration after prior aortic dissection repair in three (27%), and acute aortobronchial fistula in one patient (9%). Their average age was 72 ± 7 years. Complete arch repair from zone 0 to 4 was performed in six cases (55%); the remaining repairs landed proximally in zones 1 or 2. Seven repairs used a single retrograde facing inner branch (thoracic branch endoprosthesis; W.L. Gore & Associates), three used double antegrade inner branch (Bolton Relay; Terumo Interventional Systems), and one emergent case used double in situ fenestrations. Seven repairs (64%) used an adjunctive extra-anatomic bypass to complete great vessel perfusion, two of which were created during a prior aortic repair. Inferior vena cava balloon inflow occlusion during deployment was used in all cases. No mortalities, transient or permanent spinal cord paralysis, myocardial infarction, dialysis dependence, venous thromboembolism, or bleeding requiring reintervention occurred. No patient undergoing elective arch branch repair experienced a stroke. The one patient undergoing emergent repair did suffer a stroke. The median length of stay was 5 days (interquartile range, 2-8 days). Two endoleaks developed: a type Ia endoleak successfully treated with a Palmaz stent (Cordis) during the index admission, and a type II endoleak with ongoing sac regression on postoperative follow-up. Postoperatively, one patient suffered a suspected aortic graft infection that was treated with lifelong antibiotics. During a mean radiographic follow-up of 7.2 months, no cases of branch vessel instability (ie, no migration, reintervention, arterial rupture, intraluminal thrombus, occlusion, stenosis, or kinking of the branch grafts) developed. Three patients experienced sac regression of >5 mm, and no patient experienced continued postoperative dilation. CONCLUSIONS: To the best of our knowledge, this is the largest reported Canadian volume of aortic arch repair using novel branched or fenestrated technology. The series demonstrates that a multidisciplinary program and properly selected patients can yield excellent results using endovascular repair for complex aortic arch pathology. Elsevier 2023-07-27 /pmc/articles/PMC10562848/ /pubmed/37822947 http://dx.doi.org/10.1016/j.jvscit.2023.101274 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Innovative technique
Rockley, Mark
Rommens, Kenton L.
McClure, R. Scott
Herget, Eric J.
Smith, Holly N.
Moore, Randy D.
Aortic arch endovascular branch and fenestrated repair: Initial Canadian experience with novel technology
title Aortic arch endovascular branch and fenestrated repair: Initial Canadian experience with novel technology
title_full Aortic arch endovascular branch and fenestrated repair: Initial Canadian experience with novel technology
title_fullStr Aortic arch endovascular branch and fenestrated repair: Initial Canadian experience with novel technology
title_full_unstemmed Aortic arch endovascular branch and fenestrated repair: Initial Canadian experience with novel technology
title_short Aortic arch endovascular branch and fenestrated repair: Initial Canadian experience with novel technology
title_sort aortic arch endovascular branch and fenestrated repair: initial canadian experience with novel technology
topic Innovative technique
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562848/
https://www.ncbi.nlm.nih.gov/pubmed/37822947
http://dx.doi.org/10.1016/j.jvscit.2023.101274
work_keys_str_mv AT rockleymark aorticarchendovascularbranchandfenestratedrepairinitialcanadianexperiencewithnoveltechnology
AT rommenskentonl aorticarchendovascularbranchandfenestratedrepairinitialcanadianexperiencewithnoveltechnology
AT mcclurerscott aorticarchendovascularbranchandfenestratedrepairinitialcanadianexperiencewithnoveltechnology
AT hergetericj aorticarchendovascularbranchandfenestratedrepairinitialcanadianexperiencewithnoveltechnology
AT smithhollyn aorticarchendovascularbranchandfenestratedrepairinitialcanadianexperiencewithnoveltechnology
AT moorerandyd aorticarchendovascularbranchandfenestratedrepairinitialcanadianexperiencewithnoveltechnology